Based on these and other observations, medulloblastoma is now considered as comprised of at least four main subgroups with distinctive molecular, demographic and clinical characteristics, termed SHH, WNT, group 3 and group 4 medulloblastoma variants [72,73,74,75,76,77,78]. Here, SHH is linked to medulloblastoma.